Abstract Background Bedside insertion of Impella percutaneous ventricular assistant device
(pVAD)(Abiomed, Danvers, MA) under transesophageal echocardiographic (TEE) guidance …

Background: The Impella® percutaneous left ventricular assist device has been available in
Japan since 2017. This is the first large-scale registry study to analyze the efficacy and …

The Impella pump, alone or in combination with VA-ECMO, provides systemic support and
left ventricular (LV) unloading [1]. It is commonly placed in the catheterization laboratory …

Background Acute cardiogenic shock is associated with high mortality rates. Mechanical
circulatory devices have been increasingly used in this setting for hemodynamic support …

Objectives To describe hemodynamic efficacy and clinical outcomes of Impella
percutaneous left ventricular assist device (pLVAD) in patients with cardiogenic shock (CS) …

BACKGROUND The Impella pump has emerged as a promising tool in patients with
cardiogenic shock (CS). Despite its attractive properties, there are scarce data on the …

Impella® pumps are increasingly utilized in patients in cardiogenic shock. We report on a
case series where Impella support was insufficient, and a switch to venoarterial …

Objective The contribution of cardiogenic shock to in-hospital mortality has not decreased
significantly despite prompt revascularization, advances in medical therapy, and mechanical …

Impella assist devices have been increasingly used in cardiogenic shock (CS). This study
aims to assess the incidence of hemolysis when Impella support is used longer than 6 hours …

ABSTRACT Introduction: The Impella ventricular support system is a device that can be
inserted percutaneously or directly across the aortic valve to unload the left ventricle. The …